Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

587
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
587
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated monitoring in clinical and operational workflows.

BMJ health & care informatics·2026
Same author

Somatoform Disorders Affect Decision-making of Breast Reconstruction Post-Mastectomy of Breast Cancer Patients: A Comparative Hazard Analysis.

Aesthetic plastic surgery·2026
Same author

An evidence gap map of digital health interventions for enhancing patient engagement in healthcare.

NPJ digital medicine·2026
Same author

Real-world data analysis of cranial nerve III, IV, and VI palsies: demographics, association factors, and comparative all-cause mortality.

BMC ophthalmology·2026
Same author

Retraction notice to "Applying spectral analysis to the arterial pulse to discriminate cardiovascular side effects following administration of Moderna's mRNA-1273 vaccine" [Eur. J. Pharmacol. 1007 (2025) 178269].

European journal of pharmacology·2026
Same author

Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis Using Electronic Health Records: Multicenter Cohort Study.

JMIR formative research·2026

Related Experiment Video

Updated: May 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

A probabilistic model for reducing medication errors.

Phung Anh Nguyen1, Shabbir Syed-Abdul, Usman Iqbal

  • 1Institute of Biomedical Informatics, National Yang-Ming University, Taipei, Taiwan ; College of Medicine Science and Technology, Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan.

Plos One
|December 7, 2013
PubMed
Summary
This summary is machine-generated.

This study developed an automated appropriateness of prescription (AOP) model to identify rare drug-disease and drug-drug links, significantly reducing medication errors. The AOP model enhances patient safety and care quality by alerting physicians to potential prescription issues.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K
Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

7.6K

Related Experiment Videos

Last Updated: May 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K
Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

7.6K

Area of Science:

  • Health Informatics
  • Clinical Pharmacology
  • Data Mining

Background:

  • Medication errors pose significant risks, are costly, and preventable.
  • Information technology and automated systems are crucial in hospital settings for error prevention.
  • Identifying rare drug-disease and drug-drug associations can further reduce medication errors.

Purpose of the Study:

  • To construct a probabilistic model for reducing medication errors.
  • To identify uncommon or rare associations between medications and diseases.
  • To develop an automated appropriateness of prescription (AOP) model.

Main Methods:

  • Utilized association rule mining on a large dataset of 103.5 million prescriptions.
  • Analyzed 204.5 million diagnoses (ICD9-CM) and 347.7 million medications (ATC codes).
  • Computed Disease-Medication (DM) and Medication-Medication (MM) associations using Q values (lift).

Main Results:

  • Developed the AOP model to predict prescription appropriateness.
  • Achieved 96% accuracy for appropriate and 45% for inappropriate prescriptions.
  • Demonstrated a sensitivity of 75.9% and specificity of 89.5% through expert validation.

Conclusions:

  • Successfully developed the AOP model for automatic identification of rare prescription associations.
  • The AOP model serves as an efficient tool to reduce medication errors.
  • Improved patient safety and overall quality of care through physician alerts.